Literature DB >> 30036773

Value of schizophrenia treatment I: The patient journey.

Pavel Mohr1, Silvana Galderisi2, Patrice Boyer3, Danuta Wasserman4, Paul Arteel5, Aagje Ieven6, Hilkka Karkkainen5, Eulalia Pereira6, Nick Guldemond7, Petr Winkler8, Wolfgang Gaebel9.   

Abstract

BACKGROUND: The aim of the European Brain Council project "The Value of Treatment" was to provide evidence-based, cost-effective policy recommendations for a patient-centered and sustainable coordinated care model for brain disorders. The first part of schizophrenia study examined the needs and gaps in the patients' care pathway.
METHODS: Descriptive analysis was based on an inventory of needs and treatment opportunities, using focus group sessions, expert interviews, users' input, and literature review. Three patient pathways were selected: indicated prevention, duration of untreated psychosis, and relapse prevention.
RESULTS: The analysis identified several critical barriers to optimal treatment. Available health care services often miss or delay detection of symptoms and diagnosis in at-risk individuals. There is a lack of illness awareness among patients, families, and the public; scarcity of information, training and education among primary care providers; stigmatizing beliefs. Early symptom recognition and timely intervention result in better outcome and prognosis; effective management leads to a functional recovery. In the current model of care, there is insufficient cooperation between health and social care providers, patients and families, inadequate utilization of pharmacological and psychosocial interventions, lacking patient monitoring, and low implementation of integrated community care.
CONCLUSIONS: Early detection and early intervention programs, timely intervention, and relapse prevention are essential for effective management of schizophrenia. It requires a paradigm shift from symptom control, achieving and maintaining remission, to the emphasis on recovery. Since the current services are not able to accomplish this goal, changes in mental health policies are needed.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Mental health; Patient journey; Prevention; Recovery; Schizophrenia; Treatment

Mesh:

Year:  2018        PMID: 30036773     DOI: 10.1016/j.eurpsy.2018.06.007

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  7 in total

1.  Multidimensional analysis of adult patients' care trajectories before a first diagnosis of schizophrenia.

Authors:  Alain Vanasse; Josiane Courteau; Mireille Courteau; Marc-André Roy; Emmanuel Stip; Marie-Josée Fleury; Alain Lesage; Sébastien Brodeur
Journal:  Schizophrenia (Heidelb)       Date:  2022-05-19

2.  Benefits and limitations of business process model notation in modelling patient healthcare trajectory: a scoping review protocol.

Authors:  Said Abasse Kassim; Jean-Baptiste Gartner; Laurence Labbé; Paolo Landa; Catherine Paquet; Frédéric Bergeron; Célia Lemaire; André Côté
Journal:  BMJ Open       Date:  2022-05-30       Impact factor: 3.006

3.  Improving Medication Adherence in Community-Dwelling Patients with Schizophrenia Through Therapeutic Alliance and Medication Attitude: A Serial Multiple Mediation Model.

Authors:  Wen Ling Hsieh; Shin Ting Yeh; Wen I Liu; I Hsien Li; Shih Kai Lee; Wai Tong Chien
Journal:  Patient Prefer Adherence       Date:  2022-04-13       Impact factor: 2.314

4.  Patterns of Care for Adolescent With Schizophrenia: A Delphi-Based Consensus Study.

Authors:  Antonio Vita; Stefano Barlati; Antonello Bellomo; Paolo Fusar Poli; Gabriele Masi; Lino Nobili; Gianluca Serafini; Alessandro Zuddas; Stefano Vicari
Journal:  Front Psychiatry       Date:  2022-03-30       Impact factor: 4.157

5.  Definition and conceptualization of the patient-centered care pathway, a proposed integrative framework for consensus: a Concept analysis and systematic review.

Authors:  Jean-Baptiste Gartner; Kassim Said Abasse; Frédéric Bergeron; Paolo Landa; Célia Lemaire; André Côté
Journal:  BMC Health Serv Res       Date:  2022-04-26       Impact factor: 2.908

6.  Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients.

Authors:  Paolo Enrico; Giuseppe Delvecchio; Nunzio Turtulici; Alessandro Pigoni; Filippo Maria Villa; Cinzia Perlini; Maria Gloria Rossetti; Marcella Bellani; Antonio Lasalvia; Chiara Bonetto; Paolo Scocco; Armando D'Agostino; Stefano Torresani; Massimiliano Imbesi; Francesca Bellini; Angela Veronese; Luisella Bocchio-Chiavetto; Massimo Gennarelli; Matteo Balestrieri; Gualtiero I Colombo; Annamaria Finardi; Mirella Ruggeri; Roberto Furlan; Paolo Brambilla
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

Review 7.  A Narrative Review of the Patient Journey Through the Lens of Non-communicable Diseases in Low- and Middle-Income Countries.

Authors:  Ratna Devi; Komal Kanitkar; R Narendhar; Kawaldip Sehmi; Kannan Subramaniam
Journal:  Adv Ther       Date:  2020-10-14       Impact factor: 4.070

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.